General Kidney Stone Disease
Device Kidney Stone Disease
General payments
$1,207,625
Research payments
$255,766
Through program year 2021, $1,207,625 in general payments and $255,766 in research payments were reported against General Kidney Stone Disease (Kidney Stone Disease).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
4 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2021 | General | $174,470 | 255 |
| 2020 | General | $261 | 10 |
| 2019 | General | $1,032,894 | 1,671 |
| 2019 | Research | $255,766 | 3 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2021.
The top 5 of 11 specialties; each share is of general payments naming this product to practitioners with a specialty in 2021. Each practitioner is counted under their primary specialty.
The top 5 of 27 states; each share is of general payments naming this product in 2021 where a state was reported.
Records
1,936 general · 3 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.